首页> 美国卫生研究院文献>Endocrine Reviews >Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
【2h】

Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses

机译:激素和破坏内分泌的化学物质:低剂量效应和非单调剂量反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

For decades, studies of endocrine-disrupting chemicals (EDCs) have challenged traditional concepts in toxicology, in particular the dogma of “the dose makes the poison,” because EDCs can have effects at low doses that are not predicted by effects at higher doses. Here, we review two major concepts in EDC studies: low dose and nonmonotonicity. Low-dose effects were defined by the National Toxicology Program as those that occur in the range of human exposures or effects observed at doses below those used for traditional toxicological studies. We review the mechanistic data for low-dose effects and use a weight-of-evidence approach to analyze five examples from the EDC literature. Additionally, we explore nonmonotonic dose-response curves, defined as a nonlinear relationship between dose and effect where the slope of the curve changes sign somewhere within the range of doses examined. We provide a detailed discussion of the mechanisms responsible for generating these phenomena, plus hundreds of examples from the cell culture, animal, and epidemiology literature. We illustrate that nonmonotonic responses and low-dose effects are remarkably common in studies of natural hormones and EDCs. Whether low doses of EDCs influence certain human disorders is no longer conjecture, because epidemiological studies show that environmental exposures to EDCs are associated with human diseases and disabilities. We conclude that when nonmonotonic dose-response curves occur, the effects of low doses cannot be predicted by the effects observed at high doses. Thus, fundamental changes in chemical testing and safety determination are needed to protect human health.
机译:几十年来,对内分泌干扰化学物质(EDCs)的研究一直在挑战毒理学的传统观念,尤其是“剂量使毒药”的教条,因为EDCs在低剂量下可能会产生作用,而高剂量下的作用无法预测。在这里,我们回顾了EDC研究中的两个主要概念:低剂量和非单调性。美国国家毒理学计划将低剂量效应定义为在人类接触范围内发生的效应或以低于传统毒理学研究剂量的剂量观察到的效应。我们回顾了低剂量作用的机械数据,并使用了证据权重法来分析EDC文献中的五个例子。此外,我们研究了非单调的剂量反应曲线,定义为剂量与作用之间的非线性关系,其中曲线的斜率在所检查的剂量范围内某处发生变化。我们提供了引起这些现象的机制的详细讨论,并提供了来自细胞培养,动物和流行病学文献的数百个示例。我们说明,在自然激素和EDCs的研究中,非单调反应和低剂量效应非常普遍。低剂量的EDC是否会影响某些人类疾病已不再是一个猜测,因为流行病学研究表明,EDC的环境暴露与人类疾病和残障有关。我们得出的结论是,当出现非单调的剂量反应曲线时,无法通过在高剂量下观察到的效果来预测低剂量的作用。因此,为了保护人体健康,需要对化学测试和安全性测定进行根本性的改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号